BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17938274)

  • 1. HMGB1 preconditioning: therapeutic application for a danger signal?
    Klune JR; Billiar TR; Tsung A
    J Leukoc Biol; 2008 Mar; 83(3):558-63. PubMed ID: 17938274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.
    Erlandsson Harris H; Andersson U
    Eur J Immunol; 2004 Jun; 34(6):1503-12. PubMed ID: 15162419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGB1 as a DNA-binding cytokine.
    Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
    J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation.
    Lutz W; Stetkiewicz J
    Int J Occup Med Environ Health; 2004; 17(2):245-54. PubMed ID: 15387080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGB1, a potent proinflammatory cytokine in sepsis.
    Huang W; Tang Y; Li L
    Cytokine; 2010 Aug; 51(2):119-26. PubMed ID: 20347329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1.
    DeMarco RA; Fink MP; Lotze MT
    Mol Immunol; 2005 Feb; 42(4):433-44. PubMed ID: 15607795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inflammation and its regulatory system].
    Abeyama K; Maruyama I
    Nihon Rinsho; 2004 Dec; 62(12):2229-35. PubMed ID: 15597789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
    Hreggvidsdottir HS; Ostberg T; Wähämaa H; Schierbeck H; Aveberger AC; Klevenvall L; Palmblad K; Ottosson L; Andersson U; Harris HE
    J Leukoc Biol; 2009 Sep; 86(3):655-62. PubMed ID: 19564572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preconditioning: evolution of basic mechanisms to potential therapeutic strategies.
    Tsai BM; Wang M; March KL; Turrentine MW; Brown JW; Meldrum DR
    Shock; 2004 Mar; 21(3):195-209. PubMed ID: 14770032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytokine activity of HMGB1--extracellular escape of the nuclear protein.
    Sun NK; Chao CC
    Chang Gung Med J; 2005 Oct; 28(10):673-82. PubMed ID: 16382751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMGB1 loves company.
    Bianchi ME
    J Leukoc Biol; 2009 Sep; 86(3):573-6. PubMed ID: 19414536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).
    van Beijnum JR; Buurman WA; Griffioen AW
    Angiogenesis; 2008; 11(1):91-9. PubMed ID: 18264787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of HMGB1/RAGE in inflammatory cardiomyopathy.
    Volz HC; Kaya Z; Katus HA; Andrassy M
    Semin Thromb Hemost; 2010 Mar; 36(2):185-94. PubMed ID: 20414834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-mobility group box 1 (HMGB1) protein: friend and foe.
    Ulloa L; Messmer D
    Cytokine Growth Factor Rev; 2006 Jun; 17(3):189-201. PubMed ID: 16513409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo.
    Faraco G; Fossati S; Bianchi ME; Patrone M; Pedrazzi M; Sparatore B; Moroni F; Chiarugi A
    J Neurochem; 2007 Oct; 103(2):590-603. PubMed ID: 17666052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
    Czura CJ; Yang H; Tracey KJ
    J Infect Dis; 2003 Jun; 187 Suppl 2():S391-6. PubMed ID: 12792856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytokine activity of HMGB1.
    Yang H; Wang H; Czura CJ; Tracey KJ
    J Leukoc Biol; 2005 Jul; 78(1):1-8. PubMed ID: 15734795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of receptor for advanced glycation end-products and high mobility group box-1 attenuates septic diaphragm dysfunction in rats with peritonitis.
    Susa Y; Masuda Y; Imaizumi H; Namiki A
    Crit Care Med; 2009 Sep; 37(9):2619-24. PubMed ID: 19623040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is HMGB1 an osteocyte alarmin?
    Bidwell JP; Yang J; Robling AG
    J Cell Biochem; 2008 Apr; 103(6):1671-80. PubMed ID: 17948903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.